Get the Stockscreener App
0.1088
30.87%
0.0257
After Hours:
.20
0.0913
+83.91%
Guided Therapeutics Inc Stock (GTHP) Forecast
The Guided Therapeutics Inc (GTHP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.5005, representing a +360.27% increase from the current price of $0.1088. The highest analyst price target is $0.5016, and the lowest is $0.4995.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GTHP Price Target
Average 0.6984
(+542.20% Upside)
Long-term GTHP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Guided Therapeutics Inc financial reports and earnings history, Guided Therapeutics Inc (GTHP) stock could reach $2.1222 by 2030, $6.5374 by 2040 and $7.6226 by 2050. See the projected annual prices until 2050 of the Guided Therapeutics Inc stock below:
- Guided Therapeutics Inc (GTHP) is expected to reach an average price of $3.9593 in 2035, with a high prediction of $4.2523 and a low estimate of $4.0093. This indicates an $3,541% rise from the last recorded price of $0.1088.
- Guided Therapeutics Inc (GTHP) stock is projected to chart a bullish course in 2040, with an average price target of $6.1868, representing an $5,589% surge from its current level. The forecast ranges from a conservative $6.1868 to a sky-high $6.5374.
- Our analysts predict Guided Therapeutics Inc (GTHP) to jump 7,703% by 2045, soaring from $5.6634 to an average price of $8.4857, potentially reaching $8.7198. While $5.6634 is the low estimate, the potential upside is significant.
- Guided Therapeutics Inc (GTHP) stock is expected to climb by 2050, reaching an average of $7.3224, a $6,633% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.6226 and $7.0222, respectively, highlighting the market's uncertainty.
Guided Therapeutics Inc Stock (GTHP) Year by Year Forecast
Guided Therapeutics Inc Stock (GTHP) Price Forecast for 2025
Guided Therapeutics Inc Stock (GTHP) is expected to reach an average price of $0.5415 in 2025, with a high prediction of $0.7314 and a low estimate of $0.3516. This indicates an +397.95% rise from the last recorded price of $0.1088.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.4695 | $0.4995 | $0.5016 | +331.68% |
| June, 2025 | $0.4825 | $0.5021 | $0.4825 | +343.67% |
| July, 2025 | $0.5716 | $0.5716 | $0.5803 | +425.64% |
| August, 2025 | $0.444 | $0.5434 | $0.4683 | +308.23% |
| September, 2025 | $0.7611 | $0.4752 | $0.7314 | +599.87% |
| October, 2025 | $0.7399 | $0.7399 | $0.7108 | +580.41% |
| November, 2025 | $0.6813 | $0.6691 | $0.6397 | +526.46% |
| December, 2025 | $0.7473 | $0.7628 | $0.6873 | +587.20% |
Guided Therapeutics Inc Stock (GTHP) Price Forecast for 2026
The predicted value for Guided Therapeutics Inc (GTHP) in 2026 is set at an average of $0.8553. Estimates vary from a peak of $1.1118 to a trough of $0.5987, indicating an +686.44% surge from the present price of $0.1088.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.6082 | $0.7155 | $0.727 | +459.23% |
| February, 2026 | $0.5453 | $0.6598 | $0.5962 | +401.42% |
| March, 2026 | $0.8845 | $0.5987 | $0.9216 | +713.36% |
| April, 2026 | $0.8093 | $0.8393 | $0.8588 | +644.16% |
| May, 2026 | $0.8165 | $0.8361 | $0.7861 | +650.82% |
| June, 2026 | $0.8593 | $0.8593 | $0.8738 | +690.14% |
| July, 2026 | $0.7084 | $0.8078 | $0.7474 | +551.41% |
| August, 2026 | $1.1357 | $0.7222 | $1.1118 | +944.33% |
| September, 2026 | $1.0914 | $1.0914 | $1.0796 | +903.55% |
| October, 2026 | $1.0095 | $1.0031 | $0.9853 | +828.28% |
| November, 2026 | $1.0466 | $1.0736 | $0.9866 | +862.36% |
| December, 2026 | $0.8842 | $1.0031 | $1.0205 | +713.06% |
Guided Therapeutics Inc Stock (GTHP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Guided Therapeutics Inc (GTHP) is $1.169, with a high forecast of $1.4922 and a low forecast of $0.8458. This indicates an +974.93% increase from the last price of $0.1088.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.7982 | $0.9127 | $0.8664 | +633.93% |
| February, 2027 | $1.294 | $0.8458 | $1.302 | +1,090% |
| March, 2027 | $1.1491 | $1.1791 | $1.235 | +956.63% |
| April, 2027 | $1.1331 | $1.1701 | $1.1201 | +941.97% |
| May, 2027 | $1.1469 | $1.1469 | $1.1672 | +954.64% |
| June, 2027 | $0.9729 | $1.0723 | $1.0292 | +794.58% |
| July, 2027 | $1.5722 | $0.9693 | $1.4922 | +1,346% |
| August, 2027 | $1.4428 | $1.4428 | $1.4803 | +1,227% |
| September, 2027 | $1.3377 | $1.3371 | $1.3309 | +1,130% |
| October, 2027 | $1.3777 | $1.3845 | $1.2596 | +1,167% |
| November, 2027 | $1.1603 | $1.2892 | $1.3139 | +966.90% |
| December, 2027 | $1.051 | $1.1655 | $1.1367 | +866.45% |
Guided Therapeutics Inc Stock (GTHP) Price Forecast for 2028
In 2028, Guided Therapeutics Inc (GTHP) is projected to reach an average price of $1.5778, with a high projection of $2.0628 and a low estimate of $1.0928. This indicates an +1,351% rise from the last price of $0.1088.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6105 | $1.0928 | $1.6824 | +1,381% |
| February, 2028 | $1.4889 | $1.5189 | $1.5733 | +1,269% |
| March, 2028 | $1.4498 | $1.5041 | $1.4541 | +1,233% |
| April, 2028 | $1.4606 | $1.4986 | $1.4606 | +1,243% |
| May, 2028 | $1.2373 | $1.3367 | $1.4258 | +1,038% |
| June, 2028 | $1.9526 | $1.2164 | $1.8726 | +1,695% |
| July, 2028 | $1.7942 | $1.7942 | $1.8549 | +1,550% |
| August, 2028 | $1.6659 | $1.6711 | $1.6765 | +1,432% |
| September, 2028 | $1.6827 | $1.6953 | $1.5704 | +1,447% |
| October, 2028 | $1.4363 | $1.5652 | $1.6073 | +1,221% |
| November, 2028 | $1.3039 | $1.4184 | $1.4069 | +1,099% |
| December, 2028 | $2.0316 | $1.3399 | $2.0628 | +1,768% |
Guided Therapeutics Inc Stock (GTHP) Price Forecast for 2029
The 2029 price forecast for Guided Therapeutics Inc Stock (GTHP) is $1.9533 on average, with a high prediction of $2.4432 and a low estimate of $1.4634. This represents an +1,696% increase from the previous price of $0.1088.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.8287 | $1.8587 | $1.9611 | +1,582% |
| February, 2029 | $1.7664 | $1.8381 | $1.7881 | +1,524% |
| March, 2029 | $1.7541 | $1.7921 | $1.7541 | +1,513% |
| April, 2029 | $1.5018 | $1.6012 | $1.7135 | +1,281% |
| May, 2029 | $2.333 | $1.4634 | $2.253 | +2,045% |
| June, 2029 | $2.1091 | $2.1991 | $2.2295 | +1,839% |
| July, 2029 | $1.9942 | $2.0052 | $2.0656 | +1,734% |
| August, 2029 | $1.9877 | $2.0061 | $1.8812 | +1,728% |
| September, 2029 | $1.8338 | $1.8638 | $1.9008 | +1,586% |
| October, 2029 | $1.5567 | $1.6712 | $1.7105 | +1,331% |
| November, 2029 | $2.4004 | $1.5869 | $2.4432 | +2,107% |
| December, 2029 | $2.1685 | $2.1985 | $2.3241 | +1,894% |
Guided Therapeutics Inc Stock (GTHP) Price Forecast for 2030
Guided Therapeutics Inc Stock (GTHP) is expected to reach an average price of $2.267 in 2030, with a high forecast of $2.8236 and a low forecast of $1.7105. This signifies an +1,985% surge from the last price of $0.1088.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.083 | $2.1722 | $2.1222 | +1,815% |
| February, 2030 | $2.0475 | $2.0855 | $2.0475 | +1,783% |
| March, 2030 | $1.8123 | $1.9319 | $2.0011 | +1,566% |
| April, 2030 | $2.7134 | $1.7105 | $2.6334 | +2,395% |
| May, 2030 | $2.4663 | $2.5563 | $2.6041 | +2,168% |
| June, 2030 | $2.2892 | $2.3392 | $2.417 | +2,005% |
| July, 2030 | $2.2928 | $2.317 | $2.2399 | +2,008% |
| August, 2030 | $2.1157 | $2.1457 | $2.1942 | +1,845% |
| September, 2030 | $1.8096 | $1.9241 | $1.9866 | +1,564% |
| October, 2030 | $2.7692 | $1.834 | $2.8236 | +2,446% |
| November, 2030 | $2.5405 | $2.6727 | $2.6871 | +2,236% |
| December, 2030 | $2.3997 | $2.5062 | $2.4784 | +2,107% |
0.12%
0.08%
Cap:
|
Volume (24h):